New cancer drug enters first human trials for Tough-to-Treat tumors

NCT ID NCT04794699

Recruiting now Disease control Sponsor: IDEAYA Biosciences Source: ClinicalTrials.gov ↗

Summary

This is the first study in people testing IDE397, a new oral drug, for advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main goals are to find safe doses of IDE397 when given alone and when combined with other cancer drugs, and to see if it shows early signs of helping shrink tumors. The study will enroll about 180 adults to help determine if this experimental treatment should move forward to larger trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Advent Health
WITHDRAWN

Celebration, Florida, 34747, United States
Asan Medical Center
RECRUITING

Seoul, 05505, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
Barbara Ann Karmanos Cancer Institute
WITHDRAWN

Detroit, Michigan, 48201, United States
CHA University - Bundang Medical Center
RECRUITING

Seongnam-si, Gyeonggi-do, 28644, South Korea

Contact Email: •••••@•••••
Centre Eugène Marquis
RECRUITING

Rennes, 35000, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chungbuk National University Hospital
RECRUITING

Cheongju-si, North Chungcheong, 28644, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
City of Hope
RECRUITING

Duarte, California, 91010, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Columbia University Medical Center - Herbert Irving Pavilion
RECRUITING

New York, New York, 10032, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dana Farber Cancer Institute
RECRUITING

Boston, Massachusetts, 02115, United States

Contact Email: •••••@•••••
Hoag Memorial Hospital
RECRUITING

Newport Beach, California, 92663, United States
Honor Health Research Institute
COMPLETED

Scottsdale, Arizona, 85258, United States
Hospital Universitario 12 de Octubre (H12O)
RECRUITING

Madrid, 28041, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hôpital Timone
RECRUITING

Marseille, Marseille, 13005, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Indiana University Health Hospital
COMPLETED

Indianapolis, Indiana, 46202, United States
Institut Bergonie
RECRUITING

Bordeaux, Bordeaux Cedex, 33076, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Institut Claudius Regaud - IUCT-Oncopole
RECRUITING

Toulouse, Cedex 9, 31059, France

Contact Email: •••••@•••••
Instituto Valenciano de Oncología (IVO)
RECRUITING

Valencia, 46009, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
LifeSpan - Brown University
COMPLETED

Providence, Rhode Island, 02906, United States
MD Anderson
RECRUITING

Houston, Texas, 77030, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Markey Cancer Center
WITHDRAWN

Lexington, Kentucky, 40536, United States
NEXT Madrid, Universitary Hospital QuironSAlud
RECRUITING

Madrid, 28223, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
National Cancer Center
RECRUITING

Goyang-si, Gyeonggi-do, 10408, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
National Cheng Kung University Hospital
RECRUITING

Tainan, Tainan, 704, Taiwan

Contact Email: •••••@•••••
National Taiwan University Hospital
RECRUITING

Taipei, Taipei, 100, Taiwan

Contact Phone: •••-•••-•••• Email: •••••@•••••
Next Oncology
COMPLETED

San Antonio, Texas, 78229, United States
Orlando Health Cancer Institute
RECRUITING

Orlando, Florida, 32806, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Providence Medical Group
WITHDRAWN

Santa Rosa, California, 95403, United States
Rockefeller Cancer Institute
RECRUITING

Little Rock, Arkansas, 72205, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
START Madrid-HM - Centro Integral Oncológico Clara Campal (CIOCC)
RECRUITING

Madrid, 28050, Spain

Contact Email: •••••@•••••
Sarah Cannon Research Institute
RECRUITING

Nashville, Tennessee, 37203, United States

Contact Phone: •••-•••-••••
Sevrance Hospital
RECRUITING

Seoul, 03722, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RECRUITING

Baltimore, Maryland, 21287, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Southern Oncology Clinical Research Unit
COMPLETED

Bedford Park, South Australia, 05042, Australia
Stephenson Cancer Center
RECRUITING

Oklahoma City, Oklahoma, 73104, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Swedish Cancer Institute
RECRUITING

Seattle, Washington, 98104, United States
The Kinghorn Cancer Centre, St Vincent's Health Network Sydney
RECRUITING

Darlinghurst, New South Wales, 02010, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Universitaetsklinikum Hamburg-Eppendorf (UKE)
RECRUITING

Hamburg, 20246, Germany

Contact Email: •••••@•••••
Vall Hebron Institute of Oncology
RECRUITING

Barcelona, 08035, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••
Weill Cornell Medical College
COMPLETED

New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.

SOLID TUMOR